This is the latest episode of the free DDW narrated podcast, titled “Where is the latest innovation in neuroscience?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Taking a new approach to tackle neurodegenerative diseases, The rise of digital biomarkers in neuroscience drug development, and Keeping technology at the front of neuroscience research.
In the first article, William Erhardt, President, Head of Development & Operations of biotech Oligomerix, tells Lu Rahman about the company’s differentiated approach to developing disease-modifying therapeutics for neurodegenerative diseases.
In the second article, Dr J Mark Treherne, Dr Jenny Barnett and Dr Paula Moran answer the question of whether an expansion in the use of effective digital biomarkers will help improve the productivity of drug development in neuroscience.
In the third article, David Gray, CSO of Inscopix talks to Lu Rahman about the company’s understanding of the neuroscience market and its quest to improve technologies for neuroscientists to enable multimodal research.